PBHE315
Annotated Bibliography
Ezekiel J. Emanuel (2015, Sept 9). The Solution to Drug Prices. The New York Times, Retrieved from: https://www.nytimes.com/2015/09/09/opinion/the-solution-to-drug-prices.html This article in the New York Times addresses the high prices of prescription drugs in the United States. It summarizes some of the specialty drugs and their prices and the total expenditure on pharmaceuticals in the year 2014. The article further analyzes the government spending on Medicare and what would be the impact on those with private insurance cover if the government negotiated prices with drug companies. As part of the solution to drug prices the author compares the Australian and the Swiss models as an alternative way to go around the issue. This is a very helpful article as it provides solutions to the problems ailing the healthcare system.
United States. Senate. (2016, December 9). Sudden Price Spikes in Off-Patent Prescription Drugs: The Monopoly Business Model that Harms Patients, Taxpayers, and the U.S. Health Care System. Report by: Senator Susan M. Collins (R-ME), Chairman Senator Claire McCaskill (D-MO), Ranking Member. Retrieved from the U.S Senate website: https://www.aging.senate.gov/imo/media/doc/Drug%20Pricing%20Report.pdf This report by the US Senate gives an overview of the drug pricing in the United States, the role of Foods and Drugs Administration (FDA), in the regulation of the drugs industry, the various business models in the pharmaceuticals, high prices of life saving and generic drugs and policy responses to curb the high drug prices among other pertinent issues. This report is important to my research as the information presented is reliable and covers a broad perspective that affects the cost of pharmaceuticals from regulation, manufacturing and consumption.
References list:
Ezekiel J. Emanuel (2015, Sept 9). The Solution to Drug Prices. The New York Times, Retrieved from: https://www.nytimes.com/2015/09/09/opinion/the-solution-to-drug-prices.html
United States. Senate. (2016, December 9). Sudden Price Spikes in Off-Patent Prescription Drugs: The Monopoly Business Model that Harms Patients, Taxpayers, and the U.S. Health Care System. Report by: Senator Susan M. Collins (R-ME), Chairman Senator Claire McCaskill (D-MO), Ranking Member. Retrieved from the U.S Senate website: https://www.aging.senate.gov/imo/media/doc/Drug%20Pricing%20Report.pdf